Selskabets formål er at drive fabrikation og handel med kemiske produkter.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 52.7 mio. | 10.2 mio. | 236.1 mio. | 217.6 mio. | 39 | |
CVR: 32834825
Secondary names: BIOFAC ESBJERG A/S, ZERIA DENMARK A/S, ZERIA PHARMA DENMARK A/S
Previous names: BIOFAC ESBJERG A/S
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Companies in the same industry and area
Ken Motegi joined the board
Mitsuru Iwai left the board
Compared to 24 companies in Fremstilling af farmaceutiske råvarer
Comparison is based on industry median values